Prosecution Insights
Last updated: July 17, 2026

Goodwin Procter LLP

289 pending office actions • 154 clients • 254 examiners • 115 art units • 1 of 289 (0%) have an AI response strategy ready • 291 patents granted in the last 365 days

Quality Metrics (n=78814 apps, methodology: how we score firms)

80.7%
Allowance Rate
n=78814
+0.54σ
Allowance Rate (norm)
n=78814
3.2
OAs to Allowance
n=41385
-0.16σ
OAs to Allow (norm)
n=41385
1015 days
Time to Allowance
n=41385
+9.7pp
Interview Lift
n=78814
25.7%
RCE Rate
n=78814
1.7%
Appeal Rate
n=78814

Rejection Performance (% of received rejections ultimately overcome)

80.6%
§101 Overcome
n=1198
81.8%
§102 Overcome
n=5542
80.5%
§103 Overcome
n=22625
88.2%
§112 Overcome
n=4543

Specialization & Scale

A61K, A61P, G06F
Top CPC Subclasses
19%
Top-3 CPC Share
n=78814
80
Practitioners
n=78814
985.2
Apps / Practitioner
n=78814

Portfolio Summary

289
Total Pending OAs
190
Non-Final OAs
93
Final Rejections
6
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 129 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

64
Overdue
5
Due this week
30
Due this month
21
Due in next 60 days
9
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 129 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (64)Due ≤ 7 days (5)Due ≤ 30 days (30)Due ≤ 60 days (21)Due later (9)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

8
Hard (3%)
188
Medium (65%)
56
Easy (19%)
37
Unknown (13%)

Rejection Statute Mix

BucketCases
§101 only8 (3%)
§103 only152 (53%)
§102 only30 (10%)
§112 only25 (9%)
Double-patenting only31 (11%)
Double-patenting + other6 (2%)
No statute on record37 (13%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

158
Life Sciences
55% of docket
10
Information Tech
3% of docket
5
Communications
2% of docket
13
Semiconductors
4% of docket
68
Mechanical / Eng
24% of docket
35
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

2,890 h
Manual time on pending OAs
578 h
Time saved (low, 20%)
1,011 h
Time saved (mid, 35%)
25.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MENDEZ, MANUEL A 4 86.2% +8.2%
BARTLEY, KENNETH 3 36.1% +28.6%
SPENCER, MAXIMILIAN TOBIAS 3 30.8% +30.9%
JAVANMARD, SAHAR 3 65.2% +34.8%
ROONEY, NORA MAUREEN 2 60.3% +23.5%
SCHLIENTZ, LEAH H 2 41.9% +38.9%
ZHANG SPIERING, DONGXIU 2 38.1% +88.9%
ARCORIA, PAUL JOSEPH 2
SEAMAN, D MARGARET M 2 76.6% +8.0%
NESTOR, DONNA MICHELLE 2 57.7% +43.7%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18661020 METHODS TO DEMONSTRATE PROGRESS TOWARDS FULL ADAPTATION AND TO PRESENT POTENTIAL IMPROVEMENTS THROUGH BEHAVIORAL CHANGES MENDEZ, MANUEL A
18633816 TECHNIQUES AND DEVICES PROVIDING ADAPTIVITY AND PERSONALIZATION IN DIABETES TREATMENT MENDEZ, MANUEL A
18629121 ACTIVITY MODE FOR ARTIFICIAL PANCREAS SYSTEM MENDEZ, MANUEL A

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17800958 METHODS AND COMPOSITIONS FOR MODULATING ARGININE LEVELS IN IMMUNE CELLS DHAR, MATASHA 147d overdue
18978570 APPARATUS AND METHOD FOR INTERACTIVE PLATFORM ACCESS AUTHORIZATION MCCULLOCH JR, WILLIAM H 69d
18612112 COMPUTER-IMPLEMENTED METHOD AND SYSTEM FOR PRODUCING AN ORTHOPEDIC DEVICE CHIDIAC, NICHOLAS J 76d
19039593 FABRICATION OF POLYCRYSTALLINE SILICON NITRIDE FIBERS DAIGLER, CHRISTOPHER PAUL
17995657 SYSTEM FOR DELIVERING TARGETED CONTENT WITH CARE PREFERENCE SUGGESTIONS KANAAN, LIZA TONY
17843167 METHODS, MEDIUMS, AND SYSTEMS FOR PREDICTING MOLECULE MODIFICATIONS REYES, REGINALD R
17746461 TECHNIQUES TO DETERMINE PATTERNS IN BLOOD GLUCOSE MEASUREMENT DATA AND A USER INTERFACE FOR PRESENTATION THEREOF SASS, KIMBERLY A.
17484604 DISCOVERY ENGINE FOR INTERACTIVE VIDEOS KANG, TIMOTHY J

Interview Candidates (17)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17879923 6-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME JAVANMARD, SAHAR 147d overdue
18085792 THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE JAVANMARD, SAHAR 142d overdue
19232766 APPARATUS AND METHOD FOR SOLID PHASE EXTRACTION SCHLIENTZ, LEAH H 93d overdue
17150461 MEAL INSULIN DETERMINATION FOR IMPROVED POST PRANDIAL RESPONSE BARTLEY, KENNETH 4d overdue
17574790 Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents SCHLIENTZ, LEAH H 12d
17303925 CLOSED-LOOP DIABETES TREATMENT SYSTEM DETECTING MEAL OR MISSED BOLUS BARTLEY, KENNETH 12d
18027346 Compositions and Methods of Manufacturing Amphiphilic Block Copolymers that Form Nanoparticles in Situ ZHANG SPIERING, DONGXIU 26d
18016829 METHOD FOR CONTROLLING A PROSTHESIS OR ORTHESIS SPENCER, MAXIMILIAN TOBIAS 29d

Client Portfolio (154 clients)

Client (Assignee)Pending OAs
Insulet 39
KASHIV BIOSCIENCES, LLC 8
Ottobock 8
Waters 6
Deciphera Pharmaceuticals 6
Verastem, Inc. 6
Flagship Pioneering 5
AbbVie 5
Gritstone Bio 5
Bitsight Technologies 4
Captor Therapeutics 4
WATERS TECHNOLOGIES IRELAND LIMITED 4
GE HEALTHCARE LIMITED 3
OXIPITAL AI INC. 3
PHYKION INC. 3
Encora 3
Chinese Academy of Sciences 3
Chengdu Anticancer Bioscience LTD 3
Cockroach Labs 3
MIT 3
TENZA, INC. 3
Palleon Pharmaceuticals Inc. 3
Ascentage Pharma 3
Perfuse Therapeutics, Inc. 2
Avalyn Pharma 2
Texas Medical Center 2
Noema Pharma AG 2
Fulcrum Therapeutics 2
Corvia Medical 2
Convergent Dental 2
Esperion Therapeutics 2
Zymeworks 2
Cambridge Enterprise Limited (Gb/Gb) 2
ACCUTAR BIOTECHNOLOGY INC. 2
RAPID MICRO BIOSYSTEMS, INC. 2
Zhejiang Genfleet 2
Tango Therapeutics, Inc. 2
Nuo-Beta Pharmaceutical Technology (Shanghai) Co., Ltd. 2
University of Basel 2
Vibrant Holdings, LLC 2
NeuroDerm, Ltd. 2
U.S. Government 2
THE HOSPITAL FOR SICK CHILDREN 2
State Street 2
QURALIS CORPORATION 2
Federation Bio 2
Trevena, Inc. 2
Envisagenics 2
AKTIIA SA 1
RhinoSystems, Inc. 1
Teikoku Pharma USA Inc. 1
TR1X, INC. 1
Nogra Pharma Limited 1
Bluehalo, LLC 1
Beijing Superstring Academy of Memory Technology 1
Underground Industries LLC 1
Kidentify Pte Ltd 1
Rise Building Products LLC 1
Sertainty Corporation 1
WuXi Biologics 1
Idpair, Inc. 1
6Degrees 1
SixRing Inc. 1
NanoMosaic 1
Recentive Analytics, Inc. 1
Candel Therapeutics, Inc. 1
Insitro 1
ELEVATEBIO TECHNOLOGIES, INC. 1
Restorative Therapies, Inc. 1
Blueprint Medicines 1
Albert-Ludwigs-Universität Freiburg 1
CITIUS PHARMACEUTICALS, INC. 1
University of Bern 1
Monte Rosa Therapeutics 1
WATERS TECHNOLOGIES CORPORATION 1
Anagram Therapeutics, Inc. 1
Radiant Biotherapeutics Inc. 1
Ensoma 1
Relay Therapeutics, Inc. 1
Arsenal Medical, Inc. 1
Bial - R&D Investments, S.A. 1
Texas Heart Institute 1
Organicin Scientific, Inc. 1
NUCLEUS MEDICAL GMBH 1
Xailient 1
Ono Pharmaceutical Co., Ltd. 1
Fusion Pharmaceuticals 1
Resq Pharmaceuticals LLC 1
Shennon Biotechnologies Inc. 1
CSA Medical 1
Adrenas Therapeutics, Inc. 1
Hyalex Orthopaedics, Inc. 1
Perpay Inc. 1
Paulus Holdings Limited 1
Cartesian Therapeutics 1
Novome Biotechnologies, Inc. 1
Civitas Therapeutics 1
Carpenter Technology 1
Azalea Therapeutics, Inc. 1
University of Pittsburgh 1
Grolltex 1
Responsive Arthroscopy, Inc. 1
ReNAgade Therapeutics Management Inc. 1
DAILY HARVEST, INC. 1
Alphabet 1
Orna Therapeutics, Inc. 1
Arsenal Biosciences 1
THE UNIVERSITY OF WESTERN AUSTRALIA 1
Aro Biotherapeutics 1
Institute of Macromolecular Chemistry 1
Ori Inc. 1
Camp4 Therapeutics Corporation 1
Octave Bioscience, Inc. 1
OCTAPHARMA AG 1
SERVIER PHARMACEUTICALS LLC 1
Code Biotherapeutics, Inc. 1
BrickBio, Inc. 1
Mindlab, LLC 1
Serimmune Inc. 1
Pierian Biosciences, LLC 1
MEMORIAL SLOAN KETTERING CANCER CENTER 1
Aquinnah Pharmaceuticals, Inc. 1
Micromass UK Ltd. 1
PepTC Vaccines Limited 1
Repertoire Immune Medicines, Inc. 1
Motor Life Sciences 1
NeoTX Therapeutics Ltd. 1
Tenaya Therapeutics, Inc. 1
Feals, Inc. 1
Sky Perfect International Limited 1
Bit Bio Limited 1
Brolis Sensor Technology, Uab 1
Magenta Therapeutics, Inc. 1
BIOCONSORTIA, INC. 1
Dragonfly Therapeutics 1
University of Texas 1
UVIC INDUSTRY PARTNERSHIPS INC. 1
New York Stem Cell Foundation, Inc. 1
12343096 Canada Inc. 1
SYNEDGEN, INC. 1
Mission Bio 1
THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO 1
DiaMedica USA Inc. 1
VIRGINIA COMMONWEALTH UNIVERSITY 1
Immatics 1
JBF Interlude 2009 1
UNIVERSITY OF SOUTHAMPTON 1
Gritstone Bio, Inc. 1
Happitech B.V. 1
Entact Bio Limited 1
IDEAYA BIOSCIENCES, INC. 1
Stanford University 1
UPSIDE SERVICES, INC. 1
The MathWorks, Inc. 1

Top Art Units

Art UnitApps
378324
162310
16418
16267
16186
16256
28816
16586
37746
16355

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19425853 SYSTEM AND METHOD FOR CALIBRATIONLESS DETECTION OF BLOOD PRESSURE WITH VIDEO ACQUISITION PLATFORM Aktiia SA WARSI, YASMEEN S 3791 §102 Non-Final OA Pending Dec 18, 2025
19397828 TREATMENT OF DIABETIC RETINOPATHY USING ENDOTHELIN RECEPTOR ANTAGONISTS Perfuse Therapeutics, Inc. BASQUILL, SEAN M 1614 §103 Final Rejection Pending Nov 21, 2025
19288411 MULTI-TIERED TESTING FOR TRACKING DISEASE HETEROGENEITY Flagship Pioneering Innovations Vi, LLC SKIBINSKY, ANNA 1635 §103 Non-Final OA 50d overdue Pending Aug 01, 2025
19282184 PROCESS OF PURIFICATION OF PROTEIN Kashiv Biosciences, LLC ROONEY, NORA MAUREEN 1641 §103 Final Rejection Pending Jul 28, 2025
19250513 NASAL IRRIGATION DEVICE AND SYSTEM WITH FAUX COLLAPSIBLE CARTRIDGE ELEMENT Rhinosystems, Inc. IMPINK, MOLLIE LLEWELLYN 3799 §112 Final Rejection 29d Pending Jun 26, 2025
19232766 APPARATUS AND METHOD FOR SOLID PHASE EXTRACTION GE Healthcare Limited SCHLIENTZ, LEAH H 1618 §103 Final Rejection 93d overdue Pending Jun 09, 2025
19230884 AN IMPROVED PROCESS OF PURIFICATION OF PROTEIN Kashiv Biosciences, LLC MCDERMOTT, JEANNIE 1777 §103 Non-Final OA 32d overdue Pending Jun 06, 2025
19220387 SYSTEMS AND METHODS FOR DETERMINING ASSET IMPORTANCE IN SECURITY RISK MANAGEMENT Bitsight Technologies, Inc. MANIWANG, JOSEPH R DP Non-Final OA Pending May 28, 2025
19213573 TRANSDERMAL DELIVERY PATCH FOR TREATING PAIN Teikoku Pharma Usa, Inc. GHALI, ISIS A D 1611 §103 Final Rejection Pending May 20, 2025
19211805 ON-BODY INTERLOCK FOR DRUG DELIVERY DEVICE Insulet Corporation STIGELL, THEODORE J 3783 DPOther Final Rejection Pending May 19, 2025
19211990 METHOD FOR DETERMINING A MODEL OF AN EXTREMITY, COMPUTER-READABLE STORAGE MEDIUM AND SYSTEM Ottobock SE & Co. Kgaa ERICKSON, BENNETT S §103 Non-Final OA Pending May 19, 2025
19187537 ELECTROCHEMICAL ACTUATORS AND ACTUATOR ARRAYS Insulet Corporation LETTMAN, BRYAN MATTHEW 3746 §103 Non-Final OA 43d Pending Apr 23, 2025
19087070 POLY-DONOR CD4+ T CELLS EXPRESSING IL-10 AND USES THEREOF Tr1X, Inc. NGUYEN, QUANG 1631 §103 Non-Final OA Pending Mar 21, 2025
19083096 PROCESS OF MAKING 3-(4'-AMINOPHENYL)-2-METHOXYPROPIONIC ACID, AND ANALOGS AND INTERMEDIATES THEREOF Nogra Pharma Limited DIAMOND, ALAN D 3991 DPOther Non-Final OA Pending Mar 18, 2025
19081669 INITIAL TOTAL DAILY INSULIN SETTING FOR USER ONBOARDING Insulet Corporation PHAM, TOAN NGOC DP Non-Final OA Pending Mar 17, 2025
19039593 FABRICATION OF POLYCRYSTALLINE SILICON NITRIDE FIBERS Bluehalo, LLC DAIGLER, CHRISTOPHER PAUL §101 Non-Final OA Pending Jan 28, 2025
19035537 APPARATUS FOR GLYCEMIC CONTROL Insulet Corporation KOLOSOWSKI-GAGER, KATHERINE 3687 Other Non-Final OA 42d overdue Pending Jan 23, 2025
19022649 METHOD FOR PREPARING METALLIC COBALT THIN FILM AND METHOD FOR PREPARING COBALT SILICIDE THIN FILM BEIJING SUPERSTRING ACADEMY OF MEMORY TECHNOLOGY TALBOT, BRIAN K 1712 §103 Non-Final OA Pending Jan 15, 2025
19013936 SYSTEMS AND METHODS FOR UNDERGROUND STORAGE OF STORM AND OTHER WATER SOURCES Underground Industries LLC TOLEDO-DURAN, EDWIN J §103 Non-Final OA Pending Jan 08, 2025
19004969 LOGGING AND ANALYZING ROBOTIC PICKING DATA Oxipital AI Inc. NELESKI, ELIZABETH ROSE 3658 §103 Non-Final OA 14d Pending Dec 30, 2024
19004849 TRACKING MOVING ITEMS IN A ROBOTIC PICKING SYSTEM Oxipital AI Inc. DOROS, KAYLA RENEE 3657 §103 Non-Final OA Pending Dec 30, 2024
19004904 FILTERING AND SORTING OBJECTS IN A ROBOTIC PICKING SYSTEM Oxipital AI Inc. TRAN, KHOI H 3656 §103 Non-Final OA 28d Pending Dec 30, 2024
18978570 APPARATUS AND METHOD FOR INTERACTIVE PLATFORM ACCESS AUTHORIZATION Kidentify Pte. Ltd. MCCULLOCH JR, WILLIAM H 3715 §101 Final Rejection 69d Pending Dec 12, 2024
18974588 NINTEDANIB AND NINTEDANIB COMBINATION DRY POWDER COMPOSITIONS AND USES Avalyn Pharma Inc. ZHANG SPIERING, DONGXIU DP Non-Final OA Pending Dec 09, 2024
18958722 COMPOSITE BUILDING MATERIALS AND METHODS OF MANUFACTURE Rise Building Products LLC CHOI, PETER Y 1786 §103 Final Rejection Pending Nov 25, 2024
18957201 APPARATUS AND METHOD FOR MOBILE APPLICATION ENCRYPTION Sertainty Corporation NGUYEN, CAROLINE HOANG-ANH 2495 §103 Non-Final OA 19d Pending Nov 22, 2024
18952889 NOVEL ANTI-PD-L1 ANTIBODIES Wuxi Biologics Ireland Limited ROONEY, NORA MAUREEN §112 Non-Final OA Pending Nov 19, 2024
18940010 MULTI-FACTOR CROSS PLATFORM TRANSACTION IDENTIFICATION Idpair, Inc. SINGH, ISHAYU NMN §103 Non-Final OA Pending Nov 07, 2024
18860528 PROLONGED AIR LEAK PERCEPTION Texas Medical Center MONTICELLO, WILLIAM THOMAS 3682 §102 Non-Final OA 35d Pending Oct 25, 2024
18920112 ADAPTIVE INTRINSIC LOCK MASS CORRECTION Micromass UK Limited GUNBERG, EDWIN C 2884 Non-Final OA Pending Oct 18, 2024
18909461 WEARABLE COMPUTER POINTING APPARATUS 6Degrees Ltd. LEIBY, CHRISTOPHER E 2621 §103 Final Rejection 11d overdue Pending Oct 08, 2024
18853369 METHOD TO MANUFACTURE BIOFUEL Sixring Inc. ROBINSON, RENEE E §103 Non-Final OA Pending Oct 01, 2024
18889904 SYSTEMS AND METHODS FOR DESIGNING AND CONDUCTING CLINICAL TRIALS AND BIOMARKER VALIDATION STUDIES Flagship Pioneering Innovations Vii, LLC HEIN, DEVIN C 3686 §103 Non-Final OA Pending Sep 19, 2024
18885235 NANOSENSORS AND USE THEREOF Nanomosaic Inc. XING, CHRISTINA ILONA 2877 §103 Non-Final OA 10d overdue Pending Sep 13, 2024
18841749 TRIPLE UPTAKE INHIBITOR FOR THE TREATMENT OF ATYPICAL DEPRESSION Noema Pharma AG ARCORIA, PAUL JOSEPH §103 Non-Final OA Pending Aug 27, 2024
18799908 SYSTEMS AND METHODS FOR DETERMINING EVENT SCHEDULES Recentive Analytics, Inc. KNIGHT, LETORIA G 3623 §103 Final Rejection Pending Aug 09, 2024
18793396 METHOD FOR NUCLEAR GENOME EDITING USING PLASTID SELECTABLE MARKERS Phykion Inc. ORDAZ, CHRISTIAN JOSE 1663 §103 Non-Final OA Pending Aug 02, 2024
18786359 SYSTEM AND METHOD OF REMOTE REHABILITATION THERAPY FOR MOVEMENT DISORDERS Encora, Inc. YIP, JACK 3715 §103 Non-Final OA Pending Jul 26, 2024
18783250 MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS Fulcrum Therapeutics, Inc. SEAMAN, D MARGARET M §112 Non-Final OA Pending Jul 24, 2024
18770318 PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF Deciphera Pharmaceuticals, LLC KIFLE, BRUCK DP Non-Final OA Pending Jul 11, 2024
18760242 METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS Candel Therapeutics, Inc. WILSON, MICHAEL C 1638 DP Non-Final OA Pending Jul 01, 2024
18725965 METHOD FOR MANUFACTURING GATE-ALL-AROUND NANOSHEET STRUCTURE Institute Of Microelectronics, Chinese Academy Of Sciences ERDEM, FAZLI §103 Non-Final OA Pending Jul 01, 2024
18758622 PROCESS FOR SEPARATION AND QUANTIFICATION OF NON-IONIC SURFACTANT Kashiv Biosciences, LLC SIMMONS, VALERIE MICHELLE 1758 §103 Non-Final OA Pending Jun 28, 2024
18746658 PREDICTING CELLULAR PLURIPOTENCY USING CONTRAST IMAGES Insitro, Inc. BEG, SAMAH A 2676 DP Non-Final OA Pending Jun 18, 2024
18720877 AN IMPROVED METHOD FOR SEPARATION OF LOW MOLECULAR WEIGHT PROTEINS Kashiv Biosciences, LLC NOGUEROLA, ALEXANDER STEPHAN 1795 §112 Non-Final OA 9d Pending Jun 17, 2024
18741564 DEVICES AND METHODS FOR CORONARY SINUS PRESSURE RELIEF Corvia Medical, Inc. PRESTON, REBECCA STRASZHEIM §103 Non-Final OA Pending Jun 12, 2024
18735095 COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF Elevatebio Technologies, Inc. LEE, WILLIAM Y 1623 DP Final Rejection 36d overdue Pending Jun 05, 2024
18678378 SYSTEMS AND METHODS FOR PREDICTING CYBERSECURITY RISK BASED ON ENTITY FIRMOGRAPHICS Bitsight Technologies, Inc. NAHAR, SAYEDA S 2435 §103 Final Rejection Pending May 30, 2024
18667893 SYSTEM AND METHOD FOR PREVENTION OF DEEP-VEIN THROMBOSIS (DVT) EDEMA OR MUSCLE ATROPHY Restorative Therapies, Inc. SUL, DOUGLAS YOUNG §103 Non-Final OA Pending May 17, 2024
18667441 1H-BENZO[B]AZEPIN-2(3H)-ONE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER Chengdu Anticancer Bioscience, Ltd. NESTOR, DONNA MICHELLE §112 Non-Final OA Pending May 17, 2024
18710715 CDK2 INHIBITORS AND METHODS OF MAKING AND USING SAME BLUEPRINT MEDICINES CORPORATION MARTIN, KEVIN STEPHEN §103 Non-Final OA Pending May 16, 2024
18661020 METHODS TO DEMONSTRATE PROGRESS TOWARDS FULL ADAPTATION AND TO PRESENT POTENTIAL IMPROVEMENTS THROUGH BEHAVIORAL CHANGES Insulet Corporation MENDEZ, MANUEL A §103 Non-Final OA Pending May 10, 2024
18659379 SYSTEM AND METHOD FOR TREATMENT OF PERIODONTIC POCKETS USING DISPOSABLE INSERTS Convergent Dental, Inc. MORAN, EDWARD JOHN 3772 §103 Non-Final OA 16d Pending May 09, 2024
18708545 METHODS AND COMPOSITIONS FOR TREATING MICROGLIAL DYSFUNCTION AND IMPROVING METABOLIC DYSFUNCTION Albert-Ludwigs-Universität Freiburg FAN, LYNN Y 1759 §103 Non-Final OA Pending May 08, 2024
18708028 METHOD FOR MANUFACTURING GATE-ALL-AROUND TFET DEVICE Institute Of Microelectronics, Chinese Academy Of Sciences DAS, PINAKI §103 Non-Final OA Pending May 07, 2024
18655166 Systems and Methods for Monitoring Operations of an Infusion Delivery Device Using a Pressure Sensor Insulet Corporation RITCHIE, HADEN MATTHEW §103 Non-Final OA Pending May 03, 2024
18648288 METHODS AND SYSTEMS FOR ASSESSING HEMORRHOIDS AND TREATMENT EFFECTIVENESS THEREOF Citius Pharmaceuticals, Inc. LEE, ANDREW ELDRIDGE 3684 §102 Final Rejection Pending Apr 26, 2024
18704678 JUP BIOMARKER FOR THE DIAGNOSIS OF DISEASES OR DISORDERS OF THE FEMALE REPRODUCTIVE TRACT UNIVERSITÄT BERN KIM, YOUNG J §103 Non-Final OA Pending Apr 25, 2024
18704267 METHODS OF TREATING ABNORMAL CELL GROWTH Verastem, Inc. ARCORIA, PAUL JOSEPH §103 Non-Final OA Pending Apr 24, 2024
18640909 COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF Monte Rosa Therapeutics AG COUGHLIN, MATTHEW P §112 Non-Final OA Pending Apr 19, 2024
18634339 CHARGED AEROSOL DETECTORS Waters Technologies Corporation OLAMIT, JUSTIN N 2853 §112 Non-Final OA Pending Apr 12, 2024
18633816 TECHNIQUES AND DEVICES PROVIDING ADAPTIVITY AND PERSONALIZATION IN DIABETES TREATMENT Insulet Corporation MENDEZ, MANUEL A 3783 §103 Non-Final OA Pending Apr 12, 2024
18632996 METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME Esperion Therapeutics, Inc. MURESAN, ANA Z 1692 Other Non-Final OA 113d overdue Pending Apr 11, 2024
18629121 ACTIVITY MODE FOR ARTIFICIAL PANCREAS SYSTEM Insulet Corporation MENDEZ, MANUEL A §103 Non-Final OA Pending Apr 08, 2024
18626908 SYSTEMS AND METHODS FOR VARIABLY SCOPED, DATA-DEPENDENT READ SNAPSHOTS Cockroach Labs, Inc. MAY, ROBERT F 2154 §102 Final Rejection 19d overdue Pending Apr 04, 2024
18697203 ENGINEERED LIPASE ENZYMES, MANUFACTURE AND USE THEREOF Anagram Therapeutics, Inc. GORDON, MELENIE LEE 1651 §103 Non-Final OA Pending Mar 29, 2024
18620255 PROCESS FOR PURIFICATION OF FUSION PROTEIN Kashiv Biosciences, LLC KIM, YUNSOO 1641 DP Final Rejection Pending Mar 28, 2024
18620441 PROCESS FOR PURIFICATION OF PROTEIN Kashiv Biosciences, LLC HAQ, SHAFIQUL 1678 Other Non-Final OA 36d Pending Mar 28, 2024
18612112 COMPUTER-IMPLEMENTED METHOD AND SYSTEM FOR PRODUCING AN ORTHOPEDIC DEVICE Ottobock SE & Co. Kgaa CHIDIAC, NICHOLAS J 1744 §101 Final Rejection 76d Pending Mar 21, 2024
18612960 Bispecific Asymmetric Heterodimers Comprising Anti-CD3 Constructs Zymeworks, Inc. HUYNH, PHUONG N 1641 §103 Non-Final OA 238d overdue Pending Mar 21, 2024
18691267 OPTIMIZED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS Radiant Biotherapeutics Inc. AEDER, SEAN E DP Non-Final OA Pending Mar 12, 2024
18600407 DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS Ensoma, Inc. SABILA, MERCY HELLEN DP Non-Final OA Pending Mar 08, 2024
18598289 PRODUCTION OF HEPATOCYTES Cambridge Enterprise Limited (Gb/Gb) GU, QINHUA 1633 §103 Non-Final OA Pending Mar 07, 2024
18591704 CHROMAN DERIVATIVES HAVING ESTROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF Accutar Biotechnology Inc. KOSACK, JOSEPH R 3991 Other Non-Final OA Pending Feb 29, 2024
18685018 JAK2 INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. OTTON, ALICIA L 1629 §102 Non-Final OA Pending Feb 20, 2024
18444227 COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY Flagship Pioneering Innovations Vi, LLC DAUNER, JOSEPH G 1682 §103 Final Rejection 2d overdue Pending Feb 16, 2024
18683078 COMBINATION THERAPY USING VPS34 INHIBITORS Deciphera Pharmaceuticals, LLC PECKHAM, RICHARD GRANT 1627 DP Non-Final OA Pending Feb 12, 2024
18437804 MEDICAL DEVICE Arsenal Medical, Inc. GABR, MOHAMED GAMIL 3771 §102 Final Rejection Pending Feb 09, 2024
18437558 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial - R&D Investments, S.A. COLEMAN, BRENDA LIBBY 1624 Other Final Rejection 7d Pending Feb 09, 2024
18294893 PHRENIC NERVE PACING DEVICE Texas Heart Institute SAHAND, SANA 3796 §103 Final Rejection Pending Feb 02, 2024
18429539 SYSTEMS AND METHODS FOR INFERRING ENTITY RELATIONSHIPS VIA NETWORK COMMUNICATIONS OF USERS OR USER DEVICES Bitsight Technologies, Inc. RANDHAWA, MANDISH K 2477 Other Final Rejection 71d overdue Pending Feb 01, 2024
18425439 MULTI-MATERIAL FIBERS AND METHODS OF MANUFACTURING THE SAME Massachusetts Institute Of Technology LEE, SEUNG H 2876 §102 Non-Final OA 9d overdue Pending Jan 29, 2024
18292603 METHODS FOR SELECTING ANTIMICROBIALS AGAINST PHYTOPATHOGENS Organicin Scientific, Inc. ARIANI, KADE 1651 §103 Non-Final OA Pending Jan 26, 2024
18422986 ADAPTABLE ASYMMETRIC MEDICAMENT COST COMPONENT IN A CONTROL SYSTEM FOR MEDICAMENT DELIVERY Insulet Corporation MENDEZ, MANUEL A Non-Final OA Pending Jan 25, 2024
18410464 NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES Nucleus Medical GmbH LEE, SIN J 1613 §103 Final Rejection 14d Pending Jan 11, 2024
18406499 SYSTEMS AND METHODS FOR IMAGE PRIVACY Xailient JACKSON, JENISE E 2499 §103 Non-Final OA 9d overdue Pending Jan 08, 2024
18405777 SYSTEM AND METHOD FOR APPLYING VIBRATORY STIMULUS IN A WEARABLE DEVICE Encora, Inc. MILLER, CHRISTOPHER E §103 Non-Final OA Pending Jan 05, 2024
18404740 CHROMAN DERIVATIVES HAVING ESTROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF Accutar Biotechnology Inc. SANDERSON, LEE E 3991 DP Non-Final OA Pending Jan 04, 2024
18396017 PURINONE DERIVATIVE HYDROCHLORIDE Ono Pharmaceutical Co., Ltd. KOSAR, ANDREW D 1625 DP Non-Final OA Pending Dec 26, 2023
18572741 Degrader Compounds and Uses Thereof AbbVie Inc. SHIAO, REI TSANG 1691 Other Non-Final OA 22d Pending Dec 20, 2023
18541584 COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND FOLFIRINOX Fusion Pharmaceuticals Inc. BAEK, JONGHWAN NMN 1618 Non-Final OA Pending Dec 15, 2023
18541881 NETWORK TOPOLOGY FOR INSULIN PUMP SYSTEMS Insulet Corporation CARPENTER, WILLIAM R 3783 §103 Non-Final OA Pending Dec 15, 2023
18568440 SUBCUTANEOUS FORMULATION AND METHODS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS Resq Pharmaceuticals LLC SAEED, ALI S 1616 DP Non-Final OA Pending Dec 08, 2023
18533891 GATE-ALL-AROUND TRANSISTOR AND METHOD FOR MANUFACTURING THE SAME Institute Of Microelectronics, Chinese Academy Of Sciences CLINTON, EVAN GARRETT 2899 §103 Non-Final OA Pending Dec 08, 2023
18568165 VACUUM SYSTEM FOR A MASS SPECTROMETER Micromass UK Limited WANG, JING 2881 §103 Final Rejection 38d overdue Pending Dec 07, 2023
18530449 AUTOMATIC COMPENSATION FOR VARYING INACCURACY OF SENSOR VALUES USED BY A MEDICAMENT DELIVERY DEVICE Insulet Corporation AHMED, TASNIM M 3783 §102 Non-Final OA Pending Dec 06, 2023
18565630 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN Captor Therapeutics S.A. MOORE, SUSANNA 1624 §103 Non-Final OA Pending Nov 30, 2023
18514724 CUTTING SUBASSEMBLY AND CONDITIONING ASSEMBLY FOR AN ENVIRONMENT Rapid Micro Biosystems, Inc. BOWERS, NATHAN ANDREW 1799 §103 Non-Final OA 69d Pending Nov 20, 2023
18508634 SOLAR THERMAL AEROGEL RECEIVER AND MATERIALS THEREFOR Massachusetts Institute Of Technology BASICHAS, ALFRED 3762 §103 Non-Final OA 57d Pending Nov 14, 2023
18504790 METHODS AND SYSTEMS FOR NON-BLOCKING TRANSACTIONS Cockroach Labs, Inc. FILIPCZYK, MARCIN R 2153 §102 Non-Final OA 367d overdue Pending Nov 08, 2023
18503723 Microfluidic Devices for High Throughput Screening of Cell-Cell Interactions Shennon Biotechnologies Inc. CORDAS, EMILY ANN 1632 DP Non-Final OA Pending Nov 07, 2023
18386502 RECOMBINANT ALGAE HAVING HIGH BIOMASS AND LIPID PRODUCTIVITY Phykion Inc. JONES-FOSTER, ERICA NICOLE 1656 §112 Non-Final OA 53d Pending Nov 02, 2023
18558139 PYRIDINO-OR PYRIMIDO-CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Zhejiang Genfleet Therapeutics Co., Ltd. SHTERENGARTS, SAMANTHA L 1623 §102 Non-Final OA Pending Oct 30, 2023
18288741 COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS Chengdu Anticancer Bioscience, Ltd. SEITZ, ANTHONY JOSEPH 1629 §102 Non-Final OA Pending Oct 27, 2023
18557528 ANALYTICAL HPLC GE Healthcare Limited BRAZIN, JACQUELINE 1798 Non-Final OA Pending Oct 26, 2023
18494545 TREATMENT OF OCULAR DISEASES USING ENDOTHELIN RECEPTOR ANTAGONISTS Perfuse Therapeutics, Inc. HUANG, GIGI GEORGIANA 1613 DPOther Non-Final OA 70d Pending Oct 25, 2023
18494314 CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF Tango Therapeutics, Inc. DEKARSKE, MADELINE MCGUIRE 1622 DP Non-Final OA Pending Oct 25, 2023
18480274 ROBOTIC SYSTEM FOR DELIVERING ENERGY TO AN ANATOMICAL ELEMENT Csa Medical, Inc. LANCASTER, LINDSAY REGAN 3794 §103 Non-Final OA Pending Oct 03, 2023
18553352 POLYMORPHIC FORMS OF (S)-12-FLUORO-4-(1-METHYL-1H-PYRAZOL-5-YL)-7A,8,13,14-TETRAHYDRO-7H-[1,2,4]TRIAZOLO[4',3':1,6]PYRIDO[3,2-B]BENZOFURO[4,3-FG][1,4]OXAZONINE Fulcrum Therapeutics, Inc. HAVLIN, ROBERT H 1626 §103 Final Rejection 71d overdue Pending Sep 29, 2023
17995096 APPLICATIONS OF P14K INHIBITOR IN INTRACELLULAR PROTEIN MISFOLDING-RELATED DISEASES AND LYSOSOMAL STORAGE DISEASES Nuo-Beta Pharmaceutical Technology (Shanghai) Co., Ltd. CHONG, YONG SOO 1623 §112 Non-Final OA Pending Sep 28, 2023
18477504 HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF University of Basel PERREIRA, MELISSA JEAN 1618 §103 Non-Final OA 30d overdue Pending Sep 28, 2023
18475792 HIGH PRODUCTIVITY ALGAL MUTANTS HAVING REDUCED PHOTOSYNTHETIC ANTENNA Phykion Inc. KUMAR, VINOD 1663 §112 Final Rejection Pending Sep 27, 2023
18474682 DUAL WHEEL ACTUATOR Insulet Corporation PONTON, JAMES D 3783 §103 Non-Final OA Pending Sep 26, 2023
18474218 HIGH PURITY COPPER RADIOPHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF University of Basel LEWOCZKO, EVAN MICHAEL 1612 DP Non-Final OA Pending Sep 25, 2023
18474060 COMPOSITIONS AND METHODS FOR MAKING AND USING AN IMMORTALIZED LIBRARY Flagship Pioneering Innovations Vi, LLC DAUNER, JOSEPH G 1682 DPOther Non-Final OA 70d Pending Sep 25, 2023
18551143 GENE THERAPIES FOR 21-HYDROXYLASE DEFICIENCY Adrenas Therapeutics, Inc. AMICK, THOMAS RUSSE 1638 Other Non-Final OA 49d Pending Sep 18, 2023
18282254 PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Zhejiang Genfleet Therapeutics Co., Ltd. HEASLEY, MEGHAN CHRISTINE 1626 §102 Non-Final OA 56d Pending Sep 15, 2023
18468355 MULTI-LAYERED BIOMIMETIC OSTEOCHONDRAL IMPLANTS AND METHODS OF USING THEREOF Hyalex Orthopaedics, Inc. HOBAN, MELISSA A §103 Non-Final OA Pending Sep 15, 2023
18368931 METHODS, SYSTEMS, AND ARRAYS FOR BIOMOLECULAR ANALYSIS Vibrant Holdings, LLC BROWN, MINDY G 1634 DP Non-Final OA Pending Sep 15, 2023
18464519 METHODS OF TREATING GASTROINTESTINAL STROMAL TUMORS Deciphera Pharmaceuticals, LLC VALENROD, YEVGENY 1628 §103 Non-Final OA 24d overdue Pending Sep 11, 2023
18281388 SYNTHETIC PRE-PROTEIN SIGNAL PEPTIDES FOR DIRECTING SECRETION OF HETEROLOGOUS PROTEINS IN BACILLUS BACTERIA Tenza, Inc. GROOMS, TIFFANY NICOLE 1658 §112 Non-Final OA Pending Sep 11, 2023
18463880 COMPUTING ARCHITECTURE FOR TRANSACTION AUTHORIZATION AND MEDIUMS AND METHODS FOR THE SAME Perpay Inc. JUNG, HENRY H 3695 §102 Final Rejection Pending Sep 08, 2023
18027275 ELECTROCHEMICAL SYSTEMS AND METHODS Massachusetts Institute Of Technology RUFO, LOUIS J 1759 §112 Non-Final OA Pending Sep 08, 2023
18281117 SYNTHETIC SIGNAL PEPTIDES FOR DIRECTING SECRETION OF HETEROLOGOUS PROTEINS IN YEAST Tenza, Inc. HIBBERT, CATHERINE S 1658 DP Non-Final OA Pending Sep 08, 2023
18462918 MODULATORS OF THE INTEGRATED STRESS PATHWAY AbbVie Inc. NOLAN, JASON MICHAEL 1623 Final Rejection 118d overdue Pending Sep 07, 2023
18549452 STABILIZED LIQUID COMPOSITIONS COMPRISING A LEVODOPA-TYROSINE CONJUGATE AND USES THEREOF Neuroderm, Ltd. CHO, DAVID H 1693 Other Non-Final OA 22d Pending Sep 07, 2023
18240823 DEVICES FOR COLLECTING CAPILLARY BLOOD AND METHODS FOR SAME Paulus Holdings Limited PORTILLO, JAIRO H 3791 Other Final Rejection 45d overdue Pending Aug 31, 2023
18457825 METHODS OF TREATING DISORDERS WITH ULK INHIBITORS Deciphera Pharmaceuticals, LLC KUCKLA, ANNA GRACE 1626 §103 Final Rejection 42d Pending Aug 29, 2023
18454323 SYSTEM AND METHOD FOR ADJUSTING INSULIN DELIVERY TO ACCOUNT FOR INSULIN RESISTANCE Insulet Corporation GONZALEZ, LEI NMN 3783 §103 Non-Final OA 26d Pending Aug 23, 2023
18451333 MULTI-START LEADSCREW FOR VARIABLE FILLING AND PERFORMANCE Insulet Corporation STIMPERT, PHILIP EARL 3783 §103 Final Rejection Pending Aug 17, 2023
18546528 ION SOURCE NEBULISER Micromass UK Limited KALISZEWSKI, ALINA ROSE 2881 §103 Non-Final OA Pending Aug 15, 2023
18546312 PYRROLO[3,2-D]PYRIMIDINE COMPOUNDS AND METHODS OF USE IN THE TREATMENT OF CANCER Tango Therapeutics, Inc. NOLAN, JASON MICHAEL 1623 §112 Non-Final OA 43d overdue Pending Aug 14, 2023
18277220 Self-Assembling Nanoparticles Based On Amphiphilic Peptides The United States Department of Health and Human Services VARADARAJ, ARCHANA 1658 DP Non-Final OA Pending Aug 14, 2023
18448842 COMPOSITIONS AND METHODS RELATED TO IMMUNOGLOBULIN PROTEASES AND FUSIONS THEREOF Cartesian Therapeutics, Inc. ALFANO, ALAN 1641 §103 Non-Final OA 15d Pending Aug 11, 2023
18447656 SYSTEM AND METHOD FOR APPLYING VIBRATORY STIMULUS IN A WEARABLE DEVICE Encora, Inc. MILLER, CHRISTOPHER E 3785 §103 Non-Final OA Pending Aug 10, 2023
18264217 A METHOD OF ANALYSIS OF MASS SPECTROMETRY DATA Waters Technologies Ireland Limited NGHIEM, MICHAEL P 2857 §103 Final Rejection Pending Aug 03, 2023
18263820 COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH Verastem, Inc. SEITZ, ANTHONY JOSEPH 1629 §103 Non-Final OA Pending Aug 01, 2023
18228870 METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH BILE ACIDS Novome Biotechnologies, Inc. JACKSON-TONGUE, LAKIA J 1645 §102 Non-Final OA Pending Aug 01, 2023
18362449 DEVICES AND METHODS FOR PUNCTURING A CAPSULE TO RELEASE A POWDERED MEDICAMENT THEREFROM Civitas Therapeutics, Inc. PHILIPS, BRADLEY H 3799 §103 Non-Final OA 16d overdue Pending Jul 31, 2023
18263217 MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS The Hospital for Sick Children XIAO, YAN 1642 DP Non-Final OA Pending Jul 27, 2023
18360533 METHODS FOR THE TREATMENT OF CHILDHOOD-ONSET FLUENCY DISORDER Noema Pharma AG RAO, SAVITHA M 1691 §112 Non-Final OA 71d overdue Pending Jul 27, 2023
18355913 HIGH MOLYBDENUM DUPLEX STAINLESS STEEL Carpenter Technology Corporation HILL, STEPHANI A 1735 §103 Final Rejection Pending Jul 20, 2023
18221211 AAV VECTORS TARGETING T-CELLS Azalea Therapeutics, Inc. SU-TOBON, QIWEN NMN 1636 §112 Non-Final OA Pending Jul 12, 2023
18350223 INFORMING A USER OF ANTICIPATED INSULIN DELIVERY ACTIONS AND PROVIDING RECOMMENDED USER ACTIONS Insulet Corporation KASHYAP, ESHA PRAKASH 3783 §103 Final Rejection Pending Jul 11, 2023
18349566 SKELETAL MUSCLE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION MOLOYE, TITILAYO 1632 Other Non-Final OA 7d Pending Jul 10, 2023
18015271 HYDROGEL-BASED PACKAGING OF 2D MATERIALS-BASED BIOSENSOR DEVICES FOR ANALYTE DETECTION AND DIAGNOSTICS Grolltex, Inc. WASHINGTON, BRITNEY NICOLE 1797 §102 Non-Final OA 28d overdue Pending Jul 05, 2023
18260364 ANTI-PD-L1 ANTIBODIES AND FUSION PROTEINS THEREOF Palleon Pharmaceuticals Inc. ALSOMAIRY, SARAH ABDOALATIF 1646 §102 Non-Final OA 16d Pending Jul 05, 2023
18345371 SYSTEM AND METHOD FOR EVALUATING RISK OF HYPOGLYCEMIA OR HYPERGLYCEMIA Insulet Corporation HEALY, NOAH MICHAEL 3791 §102 Final Rejection 26d Pending Jun 30, 2023
18259868 NOVEL COMPOUNDS WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF Captor Therapeutics S.A. RZECZYCKI, PHILLIP MATTHEW 1625 §103 Non-Final OA Pending Jun 29, 2023
18340339 WEARABLE DRUG DELIVERY DEVICE WITH INCORPORATED FILTRATION Insulet Corporation ZAMORY, JUSTIN L 3783 §103 Final Rejection Pending Jun 23, 2023
18269301 METHODS OF TREATING MULTIPLE SCLEROSIS Ascentage Pharma Group Corp Limited SHIM, DAVID M. 1626 §103 Final Rejection 51d overdue Pending Jun 23, 2023
18259015 MASS AND/OR ION MOBILITY SPECTROMETRY Micromass UK Limited NGUYEN, KIET TUAN 2881 §103 Non-Final OA Pending Jun 22, 2023
18258399 METHOD OF CONTROLLING A JOINT OF AN ORTHOPAEDIC TECHNOLOGY DEVICE AND JOINT OF THIS KIND Ottobock SE & Co. Kgaa NERENBERG, RENEE FLORENCIA 3774 §103 Final Rejection 43d overdue Pending Jun 20, 2023
18337683 METHODS AND SYSTEMS FOR OPTICAL-BASED FLUID CONTROL IN A FLUID DELIVERY SYSTEM Insulet Corporation VOKES, KATHLEEN PAIGE 3783 §103 Final Rejection Pending Jun 20, 2023
18335911 PUSH-IN SUTURE ANCHOR SYSTEM Responsive Arthroscopy, Inc. SHI, KATHERINE MENGLIN 3771 §103 Non-Final OA 19d Pending Jun 15, 2023
18335836 CYCLIC LIPIDS AND METHODS OF USE THEREOF Renagade Therapeutics Management Inc. SEAMAN, D MARGARET M 1625 Other Non-Final OA 57d Pending Jun 15, 2023
18257045 FROZEN PLANT-BASED PORTIONED MILK CONCENTRATE AND METHODS OF PREPARATION THEREOF Daily Harvest, Inc. AXTELL, ASHLEY 1792 §103 Non-Final OA 42d Pending Jun 12, 2023
18256907 METHODS OF PROTEIN ANALYSIS Calico Life Sciences LLC WECKER, JENNIFER 1797 Other Non-Final OA 3d overdue AI Ready Jun 09, 2023
18330171 MODULATORS OF THE INTEGRATED STRESS PATHWAY AbbVie Inc. PATEL, SAGAR S 1626 §102 Non-Final OA 44d overdue Pending Jun 06, 2023
18265341 HETERODIMERIC IGA FC CONSTRUCTS AND METHODS OF USE THEREOF Zymeworks, Inc. MERTZ, PREMA MARIA 1674 §112 Final Rejection 5d Pending Jun 05, 2023
18328334 PROSTHETIC, ORTHOTIC OR EXOSKELETON DEVICE Otto Bock Healthcare LP HOBAN, MELISSA A 3774 §102 Non-Final OA Pending Jun 02, 2023
18203919 Controllable Transcription Cambridge Enterprise Limited (Gb/Gb) KONOPKA, CATHERINE ANNE 1635 Other Non-Final OA Pending May 31, 2023
18323538 ASSESSMENT OF PAST INSULIN DELIVERY OUTCOMES TO AUTOMATICALLY TUNE MDA SYSTEMS Insulet Corporation BARTLEY, KENNETH 3783 §103 Non-Final OA Pending May 25, 2023
18321670 DEVICES AND METHODS FOR THE TREATMENT OF HEART FAILURE Corvia Medical, Inc. STEWART, ALVIN J 3799 Other Non-Final OA 28d overdue Pending May 22, 2023
18253483 POLYPEPTIDES TARGETING DR4 AND/OR DR5 AND RELATED COMPOSITIONS AND METHODS The Hospital for Sick Children MELCHIOR, JAMES RYLAND 1658 DP Non-Final OA Pending May 18, 2023
18320126 CIRCULAR RNA COMPOSITIONS AND METHODS Orna Therapeutics, Inc. ZARA, JANE J 1637 Other Non-Final OA Pending May 18, 2023
18316851 SYSTEMS AND METHODS FOR TRANSACTION COMMIT AND LOCK RELEASE ATOP PARTITIONED CONSENSUS Cockroach Labs, Inc. ADAMS, CHARLES D 2152 §103 Non-Final OA 84d Pending May 12, 2023
18313767 INSTRUMENT FOR A MEDICAMENT DELIVERY DEVICE THAT ACTS AS NEEDLE AND CANNULA Insulet Corporation MEDWAY, SCOTT J 3783 §103 Final Rejection 86d Pending May 08, 2023
18143848 SYSTEM AND METHOD FOR LASER BASED ENDODONTIC TREATMENT Convergent Dental, Inc. HOLTZCLAW, MICHAEL T. 3796 §103 Final Rejection 23d Pending May 05, 2023
18308481 COMPOSITIONS AND METHODS OF GENOMIC MODIFICATION OF CELLS AND USES THEREOF Arsenal Biosciences, Inc. YU, DAVID TUYANG 1635 §103 Non-Final OA Pending Apr 27, 2023
18306041 COMPRESSION DETECTION AND COMPENSATION FOR A BIOLOGICAL SENSOR SECURED TO A USER Insulet Corporation GONZALEZ, LEI NMN 3783 §103 Non-Final OA 58d overdue Pending Apr 24, 2023
18249934 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER The University of Western Australia FISCHER, JOSEPH 1658 §103 Non-Final OA 26d Pending Apr 20, 2023
18302925 SYSTEMS AND METHODS FOR EXTERNAL DETECTION OF MISCONFIGURED SYSTEMS Bitsight Technologies, Inc. KORSAK, OLEG 2492 Other Final Rejection 17d overdue Pending Apr 19, 2023
18301036 FN3 Domain-siRNA Conjugates with Enzyme Replacement Therapy Aro Biotherapeutics Company GIBBS, TERRA C 1635 §103 Final Rejection Pending Apr 14, 2023
18300201 SYSTEM AND METHOD FOR CREATING OR ADJUSTING MANUAL BASAL PROFILES Insulet Corporation SEBASCO CHENG, STEPHANIE 3741 §103 Final Rejection Pending Apr 13, 2023
18125616 IMPROVED PROCESS FOR THE SEPARATION AND ANALYSIS OF PANCREATIC ENZYMES Kashiv Biosciences, LLC EDWARDS, JESSICA FAYE 1657 §103 Final Rejection 157d overdue Pending Mar 23, 2023
18027346 Compositions and Methods of Manufacturing Amphiphilic Block Copolymers that Form Nanoparticles in Situ Institute Of Macromolecular Chemistry ZHANG SPIERING, DONGXIU 1616 §103 Final Rejection 26d Pending Mar 20, 2023
18184943 METHODS, MEDIUMS, AND SYSTEMS FOR DETERMINING VARIATION RELATING TO COMPOUND STRUCTURES Waters Technologies Ireland Limited LIN, JERRY §103 Non-Final OA Pending Mar 16, 2023
18181386 CONTROL ELEMENTS FOR TRACKING AND MOVEMENT OF FURNITURE AND INTERIOR ARCHITECTURAL ELEMENTS Ori Inc. SHAFAYET, MOHAMMED 2116 §103 Non-Final OA Pending Mar 09, 2023
18177284 CHARACTERIZING FUNCTIONAL REGULATORY ELEMENTS USING MACHINE LEARNING Camp4 Therapeutics Corporation BAILEY, STEVEN WILLIAM §103 Non-Final OA Pending Mar 02, 2023
18024149 Biomarkers for Predicting Multiple Sclerosis Disease Progression Octave Bioscience, Inc. BOWERS, ERIN M 1653 DP Non-Final OA Pending Mar 01, 2023
18023668 Storage Stable Films Comprising Fibrin and/or Fibrinogen Octapharma AG MATTISON, LORI K 1619 §103 Final Rejection 34d Pending Feb 27, 2023
18173049 INTRA-INDIVIDUAL ANALYSIS FOR PRESENCE OF HEALTH CONDITIONS Flagship Pioneering Innovations Vi, LLC TURPIN, ZACHARY MARK 1682 DP Final Rejection Pending Feb 22, 2023
18111511 THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE Servier Pharmaceuticals LLC KOMATSU, LI N 1658 DP Non-Final OA Pending Feb 17, 2023
18166688 ENHANCED DNA DENDRIMERS AND METHODS OF USE THEREOF Code Biotherapeutics, Inc. LEITH, NANCY J 1636 DP Non-Final OA Pending Feb 09, 2023
18040933 STABLE CELL LINES FOR SITE-SPECIFIC INCORPORATION OF UNNATURAL AMINO ACIDS Brickbio, Inc. POPA, ILEANA 1633 §103 Non-Final OA Pending Feb 07, 2023
18106443 SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS Vibrant Holdings, LLC BUNKER, AMY M 1684 §103 Final Rejection Pending Feb 06, 2023
18163451 MACHINE LEARNING TECHNIQUES FOR DISCOVERING ERRORS AND SYSTEM READINESS CONDITIONS IN LIQUID CHROMATOGRAPHY INSTRUMENTS Waters Technologies Ireland Limited HAMMOND III, THOMAS M 2855 §112 Non-Final OA 70d Pending Feb 02, 2023
18040383 LOW MOLECULAR WEIGHT PROTEIN DEGRADERS AND THEIR APPLICATIONS Captor Therapeutics S.A. TRAN, SUSAN T 1615 §102 Final Rejection Pending Feb 02, 2023
18160724 EVENT DETECTION FOR DRUG DELIVERY SYSTEM Insulet Corporation GOLLAMUDI, NEERAJA 3783 §102 Non-Final OA Pending Jan 27, 2023
18159300 ACCELERATOR FOR MULTI-PASS MASS SPECTROMETERS Micromass UK Limited LOGIE, MICHAEL J 2881 DP Non-Final OA Pending Jan 25, 2023
18006494 COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS Ascentage Pharma Group Corp Limited BARSKY, JARED 1628 §103 Non-Final OA Pending Jan 23, 2023
18157400 TECHNIQUES AND SYSTEM FOR PARAMETER SELECTION FOR ONBOARDING AND ONGOING MANAGEMENT OF PUMP USERS Insulet Corporation LEVERETT, MARY CHANG §103 Non-Final OA Pending Jan 20, 2023
18157394 METHODS AND SYSTEMS FOR PRESSURE-BASED FLUID CONTROL IN A FLUID DELIVERY SYSTEM Insulet Corporation NORTH, ISABELLA SARAH HYO SO 3783 §103 Non-Final OA 4d overdue Pending Jan 20, 2023
18156687 Pain Medicine Combination and Uses Thereof Mindlab, LLC CHONG, YONG SOO 1623 §103 Final Rejection Pending Jan 19, 2023
18016829 METHOD FOR CONTROLLING A PROSTHESIS OR ORTHESIS Otto Bock Healthcare Products GmbH SPENCER, MAXIMILIAN TOBIAS 3774 §103 Final Rejection 29d Pending Jan 18, 2023
18016831 METHOD FOR CONTROLLING A PROSTHESIS OR ORTHESIS Otto Bock Healthcare Products GmbH SPENCER, MAXIMILIAN TOBIAS 3774 §103 Final Rejection 33d Pending Jan 18, 2023
18005012 COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH Verastem, Inc. HERNANDEZ, JACKSON J 1627 Other Final Rejection 78d overdue Pending Jan 10, 2023
18004589 FILTRATION ASSEMBLIES, CASSETTES, SYSTEMS, AND METHODS FOR FILTRATION AND CELL GROWTH Rapid Micro Biosystems, Inc. SHI, TINGCHEN 1796 §103 Final Rejection 61d Pending Jan 06, 2023
18014862 INFUSION PUMP DEPLOYMENT SYSTEMS AND METHODS Insulet Corporation PONTON, JAMES D 3783 §102 Final Rejection Pending Jan 06, 2023
18003234 RECOMBINANT SIALIDASES WITH REDUCED PROTEASE SENSITIVITY, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME Palleon Pharmaceuticals Inc. GODDARD, LAURA B 1642 DP Non-Final OA Pending Dec 23, 2022
18145772 SARS-COV-2 SERUM ANTIBODY PROFILING Serimmune Inc. ZOU, NIANXIANG 1671 §103 Non-Final OA 162d overdue Pending Dec 22, 2022
18085792 THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE Verastem, Inc. JAVANMARD, SAHAR 1622 §103 Final Rejection 142d overdue Pending Dec 21, 2022
18078240 INTERTUMORAL HOMOGENEITY DETERMINED BY MiCK ASSAY Pierian Biosciences, LLC BAEK, JONGHWAN NMN 1618 Other Non-Final OA 6d Pending Dec 09, 2022
18078269 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF Deciphera Pharmaceuticals, LLC ENGLISH, CONNOR KENNEDY 1625 §103 Final Rejection 8d overdue Pending Dec 09, 2022
18074202 METHODS AND ARRANGEMENTS FOR LIMIT ANALYSIS AND OPTIMIZATION State Street Bank And Trust Company HOANG, AMY P 2143 §103 Final Rejection Pending Dec 02, 2022
17928708 TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF GENE TRANSCRIPTS Quralis Corporation SHIN, DANA H 1635 §112 Final Rejection 80d overdue Pending Nov 30, 2022
18059170 CAPACITANCE SENSING FOR COMPONENT POSITIONING DETECTION Insulet Corporation BOBISH, CHRISTOPHER S 3746 §103 Final Rejection 16d Pending Nov 28, 2022
17999516 HIGH-COMPLEXITY SYNTHETIC GUT BACTERIAL COMMUNITIES Federation Bio, Inc. JACKSON-TONGUE, LAKIA J 1645 §102 Non-Final OA 4d overdue Pending Nov 21, 2022
17989006 METHODS AND COMPOSITIONS FOR TREATING ABNORMAL CELL GROWTH Verastem, Inc. JAVANMARD, SAHAR 1622 DP Final Rejection Pending Nov 17, 2022
17998724 METHOD AND SYSTEM FOR PREDICTING CELLULAR AGING Memorial Sloan Kettering Cancer Center NGUYEN, ALLEN H 2683 §103 Non-Final OA 43d Pending Nov 14, 2022
17985556 Continuous Administration of Dopa Decarboxylase Inhibitors and Compositions for Same Neuroderm, Ltd. WEBB, WALTER E 1612 Other Non-Final OA 52d overdue Pending Nov 11, 2022
17982187 COMPOUNDS, COMPOSITIONS AND METHODS OF USE Aquinnah Pharmaceuticals, Inc. STOCKTON, LAURA LYNNE 1626 §112 Non-Final OA Pending Nov 07, 2022
17982062 UNIFIED COMPUTING PLATFORM State Street Bank And Trust Company EL-BATHY, MOHAMED N 3624 §103 Final Rejection 49d overdue Pending Nov 07, 2022
17998012 AN ATMOSPHERIC PRESSURE IONISATION SOURCE Micromass UK Ltd. KALISZEWSKI, ALINA ROSE 2881 §103 Non-Final OA Pending Nov 04, 2022
17921509 METHODS OF TREATING ABNORMAL CELL GROWTH Verastem, Inc. HIRAKIS, SOPHIA P 1623 §103 Non-Final OA Pending Oct 26, 2022
17921257 METHODS FOR SYNTHESIZING N-(PHENYLSULFONYL)BENZAMIDE COMPOUNDS AND INTERMEDIATES THEREOF Ascentage Pharma Group Corp Limited HEITMEIER, KENDALL NICOLE 1621 §102 Final Rejection 2d overdue Pending Oct 25, 2022
18048407 CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF Gritstone Bio, Inc. LEE, HOI YAN NMN 1693 Other Non-Final OA 31d overdue Pending Oct 20, 2022
17995657 SYSTEM FOR DELIVERING TARGETED CONTENT WITH CARE PREFERENCE SUGGESTIONS Texas Medical Center KANAAN, LIZA TONY 3683 §101 Non-Final OA Pending Oct 06, 2022
17995299 CORONAVIRUS VACCINE Peptc Vaccines Limited DIBRINO, MARIANNE 1641 Other Non-Final OA 15d Pending Sep 30, 2022
17995099 DEUTERATED OXOPHENYLARSINE COMPOUND AND USE THEREOF Nuo-Beta Pharmaceutical Technology (Shanghai) Co., Ltd. JOHNSON, CHRISTOPHER LINDSAY 1691 DPOther Non-Final OA Pending Sep 29, 2022
17995074 BARCODABLE EXCHANGEABLE PEPTIDE-MHC MULTIMER LIBRARIES Repertoire Immune Medicines, Inc. BOESEN, CHRISTIAN C 1684 §103 Non-Final OA Pending Sep 29, 2022
17936554 DUAL NEEDLE VALVE FOR A WEARABLE DRUG DELIVERY DEVICE Insulet Corporation RADOMSKI, MARTIN ADAM 3783 §103 Non-Final OA Pending Sep 29, 2022
17954969 GRAPH BASED MACHINE LEARNING FOR GENERATING VALID SMALL MOLECULE COMPOUNDS Chengdu Anticancer Bioscience, Ltd. HILL, GRACELYN MARKHAM 1685 §103 Non-Final OA 35d Pending Sep 28, 2022
17911923 METHOD AND APPARATUS FOR SEPARATING IONS BY ION PEAK COMPRESSION OR EXPANSION Micromass UK Limited LOGIE, MICHAEL J 2881 §102 Final Rejection 13d Pending Sep 15, 2022
17906060 MICROBIAL CONSORTIA FOR THE TREATMENT OF DISEASE Federation Bio Inc. MOEHLMAN, ANDREW TERRY 1655 §103 Non-Final OA 9d Pending Sep 09, 2022
17929609 COMPOSITIONS AND METHODS FOR DIAGNOSING, PREVENTING, AND TREATING AMYOTROPHIC LATERAL SCLEROSIS IN PATIENTS WITH HYPOFUNCTIONAL ANTI-TRYPSIN ACTIVITY Motor Life Sciences, LLC KENYON, JOHN S 1625 §103 Non-Final OA 67d overdue Pending Sep 02, 2022
17909212 METHODS AND COMPOSITIONS FOR TREATING CANCER WITH IMMUNE CELLS Neotx Therapeutics Ltd. BEHARRY, ZANNA MARIA 1632 Other Non-Final OA 31d overdue Pending Sep 02, 2022
17908458 GENE VECTOR CONTROL BY CARDIOMYOCYTE-EXPRESSED MICRORNAS Tenaya Therapeutics, Inc. GU, QINHUA 1633 §103 Non-Final OA Pending Aug 31, 2022
17821994 DEVICES AND METHODS FOR CONTROLLING DRUG DOSAGE DELIVERY FOR AUTOMATICALLY PROVIDING A DRUG TO A PATIENT Insulet Corporation SHAH, NILAY J 3783 §103 Non-Final OA 53d Pending Aug 24, 2022
17894830 SOLID CANNABIDIOL COMPOSITIONS Feals, Inc. SHOWALTER, ALEXANDER KEITH 1629 §103 Final Rejection Pending Aug 24, 2022
17800958 METHODS AND COMPOSITIONS FOR MODULATING ARGININE LEVELS IN IMMUNE CELLS Sky Perfect International Limited DHAR, MATASHA 1632 §101 Final Rejection 147d overdue Pending Aug 19, 2022
17904038 BIO-THERAPEUTICS FOR DETECTION, DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH MUCOSAL BLEEDING Tenza, Inc. JOHANSEN, PETER N. 1644 §103 Non-Final OA 21d Pending Aug 11, 2022
17879923 6-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME Trevena, Inc. JAVANMARD, SAHAR 1622 §103 Final Rejection 147d overdue Pending Aug 03, 2022
17815928 SAFE HARBOR LOCI Bit Bio Limited BRETZ, COREY LANE 1600 §103 Final Rejection Pending Jul 28, 2022
17787828 Protein Tyrosine Phosphatase Degraders and Methods of Use Thereof AbbVie Inc. VALLE, ERNESTO 1623 §102 Non-Final OA 7d Pending Jun 21, 2022
17845275 USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA Deciphera Pharmaceuticals, LLC RODRIGUEZ, RAYNA B 1628 §103 Final Rejection 12d Pending Jun 21, 2022
17843167 METHODS, MEDIUMS, AND SYSTEMS FOR PREDICTING MOLECULE MODIFICATIONS Waters Technologies Ireland Limited REYES, REGINALD R 3684 §101 Final Rejection Pending Jun 17, 2022
17786383 APPARATUS AND METHOD FOR SOLID PHASE EXTRACTION GE Healthcare Limited SIEFKE, SAMUEL P 1758 §103 Final Rejection 29d Pending Jun 16, 2022
17782239 Systems and Methods for Measuring Concentration of an Analyte Brolis Sensor Technology, Uab SMITH, EMILIE ALINE 1686 §103 Non-Final OA Pending Jun 03, 2022
17780894 PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF Captor Therapeutics S.A. ANDERSON, REBECCA L 1626 §112 Non-Final OA Pending May 27, 2022
17746461 TECHNIQUES TO DETERMINE PATTERNS IN BLOOD GLUCOSE MEASUREMENT DATA AND A USER INTERFACE FOR PRESENTATION THEREOF Insulet Corporation SASS, KIMBERLY A. 3686 §101 Final Rejection Pending May 17, 2022
17744354 ANTIGEN-BINDING PROTEINS TARGETING SHARED NEOANTIGENS Gritstone Bio, Inc. LEE, YIE CHIA 1642 §103 Non-Final OA Pending May 13, 2022
17736738 SHARED NEOANTIGEN VACCINES Gritstone Bio, Inc. HILL, KEVIN KAI 1638 Other Final Rejection 141d overdue Pending May 04, 2022
17773422 DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS Magenta Therapeutics, Inc. CORDAS, EMILY ANN 1632 §103 Non-Final OA 70d overdue Pending Apr 29, 2022
17721492 SCREENING METHODS BIOCONSORTIA, INC. BOGGS, RUSSELL T 1663 Other Final Rejection 98d overdue Pending Apr 15, 2022
17769160 PROTEINS BINDING NKG2D, CD16 AND FLT3 Dragonfly Therapeutics, Inc. GUSTILO, ESTELLA M 1646 Other Final Rejection 2d overdue Pending Apr 14, 2022
17768922 METHODS OF TREATING CANCER WITH A STING AGONIST The Board Of Regents Of The University Of Texas System CHO, DAVID H 1693 Other Final Rejection 70d overdue Pending Apr 14, 2022
17718663 COMPENSATION FOR CALIBRATION OFFSETS IN AGENT DELIVERY DEVICES Insulet Corporation KOO, BENJAMIN K 3783 §103 Final Rejection Pending Apr 12, 2022
17767687 Chimeric Cytokine Receptors UVIC INDUSTRY PARTNERSHIPS INC. GRABER, JAMES J 1631 Other Final Rejection 26d Pending Apr 08, 2022
17766439 IMAGING SYSTEM AND METHOD OF USE THEREOF New York Stem Cell Foundation, Inc. PARK, EDWARD 2675 §103 Non-Final OA 33d Pending Apr 04, 2022
17639401 METHODS OF TREATING EPILEPSY USING THE SAME Trevena, Inc. NESTOR, DONNA MICHELLE 1627 DPOther Non-Final OA 60d Pending Mar 01, 2022
17682314 FORMULATION OF HIGHLY CONCENTRATED PHARMACOLOGICALLY ACTIVE ANTIBODY Kashiv Biosciences, LLC TAYLOR, LIA ELAN 1641 Other Non-Final OA 5d overdue Pending Feb 28, 2022
17680468 MODULAR ASSEMBLY RECEPTORS AND USES THEREOF 12343096 Canada Inc. FAUST, AMBER KATHLEEN 1643 §112 Final Rejection Pending Feb 25, 2022
17674093 DRIVE MECHANISMS FOR POSITIVE DISPLACEMENT PUMPS Insulet Corporation DESANTO, MATTHEW F 3700 §102 Non-Final OA Pending Feb 17, 2022
17635751 ORTHOPAEDIC DEVICE AND ENERGY STORAGE DEVICE Ottobock SE & Co. Kgaa DUDDEN, TERESA MARIE 3774 §103 Non-Final OA 23d overdue Pending Feb 16, 2022
17669766 COMPOSITIONS AND METHODS OF THEIR USE Synedgen, Inc. BAKSHI, PANCHAM 1623 DP Non-Final OA Pending Feb 11, 2022
17634841 Method and Apparatus for Multi-Omic Simultaneous Detection of Protein Expression, Single Nucleotide Variations, and Copy Number Variations in the Same Single Cells Mission Bio, Inc. SCHLOOP, ALLISON ELIZABETH 1683 §103 Non-Final OA 55d Pending Feb 11, 2022
17668124 INTEGRATION OF SENSORS FOR DRUG DELIVERY COMPENSATION IN AUTOMATED MEDICATION DELIVERY (AMD) SYSTEMS Insulet Corporation TAYLOR, MARISSA ENVENESIA 3783 §103 Non-Final OA Pending Feb 09, 2022
17631588 MULTI-VALENT AND MULTI-SPECIFIC NANOPARTICLE PLATFORMS AND METHODS The Governing Council of the University of Toronto HOPKINS, SAMANTHA LAKE 1641 Other Final Rejection 34d Pending Jan 31, 2022
17586238 ULINASTATIN POLYPEPTIDES FOR TREATING DISEASES Diamedica Usa Inc. HADDAD, MAHER M 1641 DP Non-Final OA 35d overdue Pending Jan 27, 2022
17581788 NEOANTIGEN IDENTIFICATION USING HOTSPOTS Gritstone Bio, Inc. WOITACH, JOSEPH T 1687 §103 Final Rejection Pending Jan 21, 2022
17574790 Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents VIRGINIA COMMONWEALTH UNIVERSITY SCHLIENTZ, LEAH H 1618 §103 Non-Final OA 12d Pending Jan 13, 2022
17624123 RECOMBINANT SIALIDASES AND METHODS OF USING THE SAME Palleon Pharmaceuticals Inc. WEHBE, ANNE MARIE SABRINA 1634 §102 Non-Final OA 43d overdue Pending Dec 30, 2021
17553017 T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME AGAINST PRAME POSITIVE CANCERS Immatics Biotechnologies GmbH WEHBE, ANNE MARIE SABRINA 1634 Non-Final OA Pending Dec 16, 2021
17545256 DRUG DELIVERY SYSTEM WITH SENSOR HAVING OPTIMIZED COMMUNICATION AND INFUSION SITE Insulet Corporation RADOMSKI, MARTIN ADAM 3783 §103 Final Rejection Pending Dec 08, 2021
17616350 OLIGONUCLEOTIDES AND METHODS OF USE FOR TREATING NEUROLOGICAL DISEASES Quralis Corporation RAVINDRA, KRISHNA NUGGEHALLI 1636 §103 Final Rejection Pending Dec 03, 2021
17457518 INFUSION PUMP SYSTEM AND METHOD Insulet Corporation KASHYAP, ESHA PRAKASH 3783 §112 Non-Final OA 33d Pending Dec 03, 2021
17604227 Compositions and Methods of Manufacturing Star Polymers for Ligand Display and/or Drug Delivery The United States Department of Health and Human Services KAMM, JUDITH MARIE 1611 §103 Final Rejection 1d overdue Pending Oct 15, 2021
17495266 CANCER-SPECIFIC MOLECULES AND METHODS OF USE THEREOF Envisagenics, Inc. DACE DENITO, ALEXANDRA GERALDINE 1636 §112 Final Rejection 43d overdue Pending Oct 06, 2021
17484604 DISCOVERY ENGINE FOR INTERACTIVE VIDEOS Jbf Interlude 2009 Ltd. KANG, TIMOTHY J 3689 §101 Non-Final OA Pending Sep 24, 2021
17440067 PEPTIDE-INDUCED NK CELL ACTIVATION UNIVERSITY OF SOUTHAMPTON DICKINSON, PAUL W 1618 §103 Non-Final OA 27d Pending Sep 16, 2021
17436367 IDENTIFICATION OF NEOANTIGENS WITH MHC CLASS II MODEL Gritstone Bio, Inc. NGUYEN, PETER 1685 Other Final Rejection Pending Sep 03, 2021
17446807 PRODRUG MODULATORS OF THE INTEGRATED STRESS PATHWAY AbbVie Inc. SHTERENGARTS, SAMANTHA L 1623 §112 Non-Final OA Pending Sep 02, 2021
17412684 SYSTEMS AND METHODS FOR ACTIVATING DRUG DELIVERY DEVICES Insulet Corporation VU, QUYNH-NHU HOANG 3783 §103 Non-Final OA 29d Pending Aug 26, 2021
17433817 SELECTION OF T CELL RECEPTORS Gritstone Bio, Inc. FAUST, AMBER KATHLEEN 1643 §103 Final Rejection Pending Aug 25, 2021
17396119 METHOD OF PROVIDING SPOKEN INSTRUCTIONS FOR A DEVICE FOR DETERMINING A HEARTBEAT Happitech B.V. SISON, CHRISTINE ANDREA PAN 3796 §103 Non-Final OA Pending Aug 06, 2021
17426141 SURVIVAL-TARGETING CHIMERIC (SURTAC) MOLECULES Entact Bio Limited YAO, LEI 1642 §112 Non-Final OA 3d overdue Pending Jul 28, 2021
17420833 TREATMENT OF CANCER HAVING GNAQ OR GNA11 GENETIC MUTATIONS WITH PROTEIN KINASE C INHIBITORS Ideaya Biosciences, Inc. YOO, SUN JAE 1621 §102 Non-Final OA Pending Jul 06, 2021
17303925 CLOSED-LOOP DIABETES TREATMENT SYSTEM DETECTING MEAL OR MISSED BOLUS Insulet Corporation BARTLEY, KENNETH 3684 §103 Non-Final OA 12d Pending Jun 10, 2021
17296012 HIGH COMPLEXITY SYNTHETIC GUT BACTERIAL COMMUNITIES The Board Of Trustees Of The Leland Stanford Junior University SINGH, SATYENDRA K 1657 §103 Final Rejection Pending May 21, 2021
17271045 METHODS FOR REDUCING THE RISK OF DIABETES IN PATIENTS BEING TREATED FOR HIGH CHOLESTEROL-RELATED ILLNESSES Esperion Therapeutics, Inc. HUTTER, GILLIAN A 1625 §102 Non-Final OA 57d Pending Feb 24, 2021
17157043 Dynamically Changing Promotions Displayed on a Mobile Device and Measuring The Benefit Thereof UPSIDE SERVICES, INC. OSMAN BILAL AHMED, AFAF 3622 §103 Final Rejection 147d overdue Pending Jan 25, 2021
17150461 MEAL INSULIN DETERMINATION FOR IMPROVED POST PRANDIAL RESPONSE Insulet Corporation BARTLEY, KENNETH 3684 §103 Non-Final OA 4d overdue Pending Jan 15, 2021
16952231 SYSTEMS AND METHODS FOR ANALYSIS OF ALTERNATIVE SPLICING Envisagenics, Inc. VASSELL, MEREDITH ABBOTT 1687 §103 Final Rejection Pending Nov 19, 2020
17054400 ARTIFICIAL FOOT Ottobock SE & Co. Kgaa SPENCER, MAXIMILIAN TOBIAS 3774 §103 Non-Final OA Pending Nov 10, 2020
17028595 INHALED IMATINIB FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) Avalyn Pharma Inc. HAGHIGHATIAN, MINA 1616 §103 Non-Final OA 45d overdue Pending Sep 22, 2020
17008054 TECHNIQUES FOR DETERMINING INSULIN FORMULATIONS IN AN AUTOMATED INSULIN DELIVERY SYSTEM Insulet Corporation DANIEL, ANTARIUS S 3783 §103 Final Rejection Pending Aug 31, 2020
16990291 PARALLEL IMPLEMENTATIONS OF FRAME FILTERS WITH RECURSIVE TRANSFER FUNCTIONS The MathWorks, Inc. SINGH, AMNEET 2633 §103 Final Rejection 11d overdue Pending Aug 11, 2020

Managing Goodwin Procter LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month